Show simple item record

dc.date.accessioned2020
dc.date.available2020
dc.date.issued2020
dc.identifier.govdocPAHO/NMH/NV/COVID-19/20-0021
dc.identifier.urihttps://iris.paho.org/handle/10665.2/52260
dc.description.abstractIndividuals with diabetes have a higher risk of developingvsevere symptoms and dying from COVID-19 than persons without diabetes. For examples, some studies show that approximately 20% of persons hospitalized as a result of COVID-19 have diabetes and approximately 26% of individuals who die from COVID-19 have diabetes. At the same time, however, individuals with diabetes are at increased risk of developing diabetes-related complications as a result of COVID-19-related restrictions. These complications include severe hyperglycemia, diabetic ketoacidosis, skin and soft-tissue infections, and foot ulcers. The increased risk of complications is due to multiple factors: limited access to primary care services as a result of social distancing measures, disrupted access to chronic medications, challenges obtaining refill approvals, accessing pharmacies, and supply chain shortages. This is compounded by difficulty in adhering to healthy lifestyle during COVID-19 restrictions: limited physical activity and increased sedentary behavior, limited access to fruits and vegetables, and overall greater food insecurity. Primary care health centers and providers who care for individuals with diabetes have an important role to play in ensuring continued access to care, reduced risk of infection, and appropriately managing patients with these comorbidities who acquire COVID-19. The following are considerations for the management of people with diabetes in the era of COVID-19...en_US
dc.language.isoenen_US
dc.publisherPAHOen_US
dc.rightsAttribution-NonCommercial-ShareAlike 3.0 IGO*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/3.0/igo/*
dc.subjectCOVID-19en_US
dc.subjectCoronavirusen_US
dc.subjectRisk Factorsen_US
dc.subjectVulnerable Populationsen_US
dc.subjectDiabetes Mellitusen_US
dc.titleManaging People with Diabetes during the COVID-19 Pandemic: Considerations for Health Providers, 3 June 2020en_US
dc.typeFact sheetsen_US
dc.rights.holderPan American Health Organizationen_US
dc.contributor.corporatenamePan American Health Organizationen_US
paho.isfeatured0en_US
paho.publisher.countryUnited Statesen_US
paho.publisher.cityWashington, D.C.en_US
paho.source.centercodeUS1.1en_US
paho.relation.languageVersion10665.2/52382
paho.contributor.departmentNoncommunicable Diseases and Mental Health (NMH)en_US
paho.iswhotranslationNoen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-ShareAlike 3.0 IGO
This notice should be preserved along with the article's original URL.Attribution-NonCommercial-ShareAlike 3.0 IGO